Of course, there still has to be an appeal mechanism, whether through the courts or through an administrative process, if conciliation fails and any individual believes he or she has been unjustly dealt with, for example by wrongful dismissal. But such mechanisms are available and are at leastdesigned for the purpose of considering wider issues of discipline and management, rather than individual professional competence. The latter is at once a relatively narrow and technical issue, and at the same time one of professional life or death.
That the instrument that had to be used in this case was the wrong instrument is underlined by the continuing controversies among the obstetricians and gynaecologists in Tower Hamlets. One hopesfor patients most of all -that the past can be buried and an effective service re-established. But the Inquiry was a diversion from facing up to the real issues.
We need an expert conciliation service in personnel matters to help resolve such management disputes between doctors. Who is going to establish it? mately 12 months intervened between the incidents that formed the basis for complaint and the suspension of Mrs Savage by the health authority. That cannot be a good precedent. Any incident serious enough to constitute grounds for a charge of incompetence should -except in the rarest circumstances -lead promptly to a decision whether to suspend. Not only is that important for the individual concerned, so that the evidence is still current, it must also be fundamental for the protection of patients.
Once the suspension had taken place, the Inquiry proceeded with relatively little delay. That has not always happened in similar cases. One trembles to conceive the effect on any doctor and her/his family of prolonged suspension before such a matter is heard.
The decision that the Inquiry should take place in public was most unusual. From the beginning Mrs Savage wished it to take place in public, but Mr Beaumont (as chairman of the panel) agreed only when Tower Hamlets District Health Authority also decided, by a majority, that it too favoured a public hearing. While there could be instances where this would be in the interests of justice and of public policy, this was probably not one of them, since a hearing in camera would have made absolutely no difference to the outcome and there were no major issues of obstetric practice at stake. A public hearing probably magnified the harm done to public confidence in the profession. It certainly increased the stress associated with media attention, and made it much more difficult to preserve confidentiality. On the other hand, faced with two parties both requesting a public hearing, any future chairman might well come to exactly the same decision as Mr Beaumont.
Some procedure like an HM(61)112 Inquiry is probably essential as a last resort for handling disputed cases of alleged incompetence, but it is a very expensive and blunt instrument. We should use it only with extreme reluctance, because of the harm that it is likely to do in the short term to everybody involved, and because of its cost. When it is used, suspension should normally follow the relevant incidents much faster than in this case and be based on medical advice of total objectivity and high competence in the specialty concerned. Nominating assessors for this purpose must surely be a responsibility placed squarely on the profession, for example through the relevant Royal College.
There remains the vital point that when (as in this case) the key problem is one of personalities within a unit, it is essentially a management issue, not an issue of professional competence. An HM(61)112 Inquiry is not the right mechanism for handling that class of problems. When local attempts at resolution fail, we need a high quality conciliation team available -what Sir Anthony Alment attractively described as a 'Red Adair' from the profession of personnel management to put out the fires of personal conflict before they erupt into major enquiries. Note that the professional skills required are essentially personnel skills, not medical skills. Nevertheless, there is an inescapable medical responsibility to see that such a service becomes available and to cooperate with it, since those who suffer most from such medical management disputes are patients. The Hippocratic oath always to put patients' interests first applies as much to physicians collectively as individually.
RJMaxwell
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The rheological properties of blood can vary substantially and rapidly in response to a number of normal and pathological stimuli. The influence of changes in the plasma environment is a particularly common cause of these variationsI. The opening day of a twoday meeting held by the Forum on Clinical Haemorheology in September 1986was devoted primarily to a discussion of how the effective plasmatic agents act.
There are two main ways in which the plasma influences the flow properties of blood. Firstly, variation in the viscosity of plasma will directly affect that of whole blood and, to a good approximation, in the same proportion: i.e. a 10% increase in plasma viscosity will lead to a 10% increase in whole blood viscosity, at least at high shear rate". Such changes are due largely to alterations in the plasma protein concentration. However, there is a second influence of the plasma which is more complex and less well understood. It results from the effect of certain plasma proteins, which make the erythrocytes adhesive so that they tend to stick to one another and to form characteristic aggregates known as rouleaux. This phenomenon is of rheological significance because it leads to a dramatic increase in blood viscosity at low shear ra tea and has been reported to endow blood with a yield stress. All of these effects of plasma are generally thought to affect blood flow, especially in certain In the event, much of the discussion on the first day of the meeting was concerned with rouleaux formation. It has long been known that a number of the larger plasma proteins, and especially fibrinogen, will induce rouleaux formation, as will some artificial polymers such as dextran, and the mechanism is usually taken to be a simple bridging one with the long molecules adhering to adjacent cell membranes to hold them together". What has received relatively little attention in the past is the possibility of variation between cells in their ability to form rouleaux. Professor H J Meiselman (University of Southern California) threw some light on this area by his presentation of work done by his group on normal red cells which had been separated as a function of age. He found that the oldest cells had a much greater tendency to aggregate when re-suspended in plasma or in the presence of dextran. Furthermore, a similar difference was found even in blood from homozygous sicklers, where the mean cell age is much less than that of normal subjects. The obvious question, then, is what is the cause? The answer is still unclear, but Professor Meiselman presented data which point to the idea that the older cells are able to interact more strongly with the rouleaux-forming agents, and hence that the aging process somehow exposes more binding sites. It does raise the interesting possibility that the extra stickiness of the oldest cells may be a senescence marker on the cells, signalling them for destruction by the reticuloendothelial system.
In a related paper, Professor M R Boisseau (Hopital Cardiologique, Bordeaux) reported that the concentration in plasma of particularly fibrinogen, but also a number of other large plasma proteins such as U 2 macroglobulin and Factor VIII, was correlated with impaired filterability of erythrocytes and that this related to the poor filterability of cells from patients with inflammatory diseases and associated hyperfibrinogenaemia. He therefore studied the adsorbed proteins on red cells from his control and patient groups, and found that the pattern of adsorbed proteins was different in the two groups. Finally, he used washed red cells from his two sets ofsubjects and studied their ability to adsorb purified human fibrinogen to their membranes. He found that the patients showed much greater adsorbing power than the controls though, as with Professor Meiselman's data, the reasons are obscure.
A third paper by Mr P Fearnley Whittingstall (St Mary's Hospital Medical School, London) was concerned with proteins other than fibrinogen that can lead to rouleaux formation. The presence of weak aggregation even in serum makes it clear that such proteins exist, and experiments with serum proteins separated as a function of molecular weight by gel filtration chromatography point to a 2 macroglobulin, IgM and IgG being the main contributors. However, there is still a question of whether in the mixed plasma environment their combined effect is purely additive or more complex than that. Pointing to the latter direction, he showed evidence that some small proteins such as terminal plasmin-derived fibrinogen degradation products (and possibly albumin), which of themselves are not rouleaux forming, seem to enhance the aggregating effect of fibrinogen.
Because of this concentration on rouleaux formation, it was germane that one speaker should discuss methods for quantitating it. Dr M W Rampling (St Mary's Hospital Medical School, London) started with a comparison of three of the more traditional methods based on microscopic counting techniques, low shear rate viscosity, and the erythrocyte sedimentation rate", They all have an important place in the laboratory, especially the microscopic technique based on that of Chien and Jan 5 , which is the only unambiguous method since with it rouleaux are directly observed. However, they have limitations in the routine clinical situation of being variously costly, technically complex, relatively expensive on blood usage and time-consuming. Hence the new Myrenne Erythrocyte Aggregometer (Myrenne GMBH Roetgen, West Germany) is a very interesting new development. It is based on the observation of the change in light transmission of a blood sample in a miniaturized cone-and-plate viscometer. He presented data showing that it is very sensitive to rouleaux formation, but equally important from the point of view of its use in a clinical setting, it requires a mere 25111 of sample, gives a reading in about one minute and is extremely simple to operate. He also discussed another new device, the Paar Oscillating Capillary Rheometer (Anton Paar KG Graz, Austria), this being a very novel device designed to measure the viscoelastic properties of the sample under test. With it, it is possible to obtain not only the viscosity of blood but also its elastic constant. The latter property reflects, at least in part, the effect of rouleaux formation within the test sample. The ability to obtain the elastic constant is unique, and the fact that the measurements are made in non-equilibrium conditions make this a very interesting new research tool.
A number of clinical papers followed, of which that by Dr G D 0 Lowe (Glasgow Royal Infirmary) was particularly interesting. He discussed the results of a study of the prognostic importance of blood rheology in acute stroke. Rheological data of patients who died in the first year post-stroke were compared with data from survivors. He found that the patients who died had a higher whole blood viscosity at high and low shear rates. The main reasons for this were the higher plasma viscosity and fibrinogen concentration and the resultant higher rouleaux formation found in these patients, though they also showed evidence for reduced erythrocyte deformability, which is likely to have had an additional influence on the viscosity characteristics of their blood.
On the second day the main topic was the haemorheology of the neonate, which exhibits a number of differences from that of the adult. An area where difference might be expected is in the erythrocyte itself, since it is well known that neonatal red cells are larger and have some variations in membrane constituents as compared with the adult". Professor 0 Linderkamp (University of Heidelberg) discussed his detailed study of the mechanics of these cells. Using a variety of micropipette techniques and the rheoscope, he was able to compare membrane mechanical properties of neonatal erythrocytes with those of the adult. He found small but significant differences in many of these: thus, for example, extensional and bending moduli were smaller by 10% and 16% respectively than in the adult, and the time constant for recovery from deformation was increased. However, looking at the properties of the whole cell, the aspiration pressure necessary to draw a cell into a small 3.311m pipette (as a model of a capillary) was generally higher in the neonate, but this was due to the cells being larger. When the experiments were done on cells of the same MCV, the neonatal ones required a slightly lower pressure. Hence he concluded that the two types of cells do show small but significant differences in their membrane properties and these, he hypothesized, may be part of the reason for the shorter lifetime of neonatal cells. A related paper by Dr T Kamalati (Kings College Hospital Medical School, London) concerned the use of electron spin resonance to study the molecular fluidity of neonatal erythrocyte membranes. The probe she used was 5 doxy l-stearic acid, which gives information on the freedom of movement of the lipids in the membrane. It was clear that in the neonate this form of fluidity is increased compared to adults. What is, however, not yet clear is the relationship of such molecular fluidity data to mechanical data such as reported by Professor Linderkamp. Nevertheless, it is interesting that she has also found decreased erythrocyte membrane fluidity in severe peripheral vascular disease patients where evidence exists for mechanical deformability to be decreased'.
Dr M W Rampling returned to the platform to talk more generally about neonatal haemorheology. He showed that usually the viscosity of neonatal blood was reduced compared to that of the adult. In part this was due to the lower plasma viscosity in the newborn due to lowered plasma protein concentrations, but there was a greater reduction at low shear rate than this alone would explain. The reason appeared to relate to the lower level of rouleaux formation found in the neonate. He presented data showing that this was not the result of differences in the red cells but rather due to plasma differences. Furthermore, while the lowered fibrinogen level common in the newborn was partly responsible, it did not provide a full explanation. He suggested that the answer might lie in the presence of the fetal variant of fibrinogen in the neonatal plasma which, because of its higher sialic acid content, would tend to interact less with the erythrocyte.
Other sessions on obstetric haemorheology and free communications completed a stimulating and enjoyable two days. However, what was particularly gratifying about this meeting was the presence of a large number of participants from the Continent. Considerable effort had been made to entice European haemorheologists to this British meeting in the hope of breaking down the insularity of the national haemorheology groups. This appears to have been successful, as joint meetings between the British and European groups are now being planned.
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